Comprising a varied landscape of antacids, antiulcerants, vitamins and minerals, antiemetics, antinauseants, antidiarrheals and anti-obesity products, the gastrointestinal drugs market is segmented into a variety of oral solid dosage forms that require a wide range of different production techniques.
For example, for products that have to act in the stomach, effervescent dosages are often preferred. By contrast, for products that have to act in the intestines, MUPS or coated tablets are more prevalent.
Many of these products have to be produced in high volumes as they represent a large portion of the over-the-counter (OTC) market.
Whatever your application, GEA can supply the right equipment and technology for your production requirements: from integrated granulation lines for high-volume production and single-pot processors adapted to effervescent processing to tablet presses that can handle MUPS or effervescent formulations.
For coating applications, available technologies include fluid bed coating for smaller particles, such as powders, granules, seeds, crystals, pellets and small tablets, a multipurpose processor that uses proven fluid bed technology to achieve granulation, drying and pellet coating (or tablet coating) in a single processor and a continuous tablet coater that accurately deposits controlled amounts of coating materials on tablets, even if they are hygroscopic or friable.
Showing 4 of 26
Combining process monitoring using online analyzers, together with solid process engineering principles and advanced process modelling techniques will enable processes to be actively controlled in order to compensate for input variations.
Innovative CIP concepts of GEA meet comprehensive high standards. Our experts guarantee product safety at every point of the process. Every upgrade is adapted to individual local conditions and customer requirements and leads to noticeable savings.
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
GEA is one of the world’s largest systems suppliers for the food, beverage and pharmaceutical sectors. Our portfolio includes machinery and plants as well as advanced process technology, components and comprehensive services. Used across diverse industries, they enhance the sustainability and efficiency of production processes globally.
GEA is listed in the German MDAX and the STOXX® Europe 600 Index and is also among the companies comprising the DAX 50 ESG and MSCI Global Sustainability Indices.
© GEA Group Aktiengesellschaft 2024Cookie settings